LY3457263
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LY3457263, covering 2026-04-17 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide [Phase 2]